Testing a thin light-based needle probe during prostate biopsy
Tests a thin light-based needle probe that examines prostate tissue in men with prostate cancer.
Key facts
- Who runs it
- University of Michigan Rogel Cancer Center
- Where
- Ann Arbor, United StatesSee the site
- Trial code
- Registry title
- Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic Probe
- Status
- Recruiting
- People taking part
- 50 people, planned
- Started
- 16 Oct 2023
- Expected to end
- Oct 2027
- Type of study
- Observational
- Treatments tested
- Fine Needle Photoacoustic Probe
- Record updated
- 9 November 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for men who already have a prostate biopsy planned as part of routine care. The new needle probe is tested during that biopsy.
- Age
- Over 40 and under 80 years old.
- Sex
- Men only.
Main reasons for not taking part
- A known bleeding disorder
- Taking anticoagulants, no matter the dose or washout time
- A known allergy to silicone material
- Unable to give informed consent
- Taking part in other investigational studies
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- 1) Planned prostate biopsy as part of routine clinical care
- 2) > 40 and <80 years old
Who cannot take part
- 2) Patients taking anticoagulants, no matter doses or washout time
- 1) Known history of bleeding disorders or
- 3) Known allergy to silicone material
- 4) Unable to provide informed consent
- 5) Either the surgeon or the patient do not think the patient will not be able to complete all parts of the study, the patient will be excluded
- 6) Involved in other investigational studies
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 40 and 80 years old?
Where in United States
- University of Michigan Rogel Cancer CenterAnn Arbor, United StatesContact: Cancer AnswerLineTaking people
About the trial
What the trial wants to find out
In this project, we will integrate the Photoacoustic (PA) technology into a prostate biopsy procedure through a fine needle probe. The needle probe will be in the shape of a biopsy needle and compatible with the needle insertion mechanism in the transrectal ultrasound (TRUS) probe. When inserted into the prostate, the fine needle PA probe will assess the histological information in its surrounding tissue without any tissue extraction. The needle probe has been tested in prostate tissue samples and whole human prostates ex vivo.
The group in the trial
- Biopsy
Patients will be identified once prostate biopsies have been scheduled. Once enrolled on trial, patients will undergo standard biopsy procedure as per clinical care. During this biopsy, research measurements will be completed using the fine needle photoacoustic probe.
Treatment: Fine Needle Photoacoustic Probe
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic Probe
- Plain-language title
- Testing a thin light-based needle probe during prostate biopsyGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT05965180, who can take part
- Record updated
- 9 November 2026